Adjuvant Durvalumab Beneficial in Esophageal/GEJ Cancer?

Cancer Network spoke with Dr. Hirva Mamdani about the role and efficacy of adjuvant durvalumab in patients with Esophageal/GEJ Cancer.

Source: CancerNetwork - January 22, 2019 Category: Cancer & Oncology Authors: Hirva Mamdani, MD Source Type: news